BARD1 Life Sciences Limited announced the appointment of Australian scientist Professor Allan Cripps as an independent Non-Executive Director, effective 23 January 2020. Professor Cripps had near 20 years' experience in the health and pharmaceutical industries before becoming a full-time academic focusing his research on mucosal immunology, respiratory tract infections, vaccine development and diagnostics. He has published over 300 peer reviewed scientific papers, presented at numerous international scientific conferences, received over $17 million in Government and industry grant funding and is co-inventor on several international patents in the fields of diagnostics and vaccine protein antigens. Currently Professor Cripps is Independent Chair of the Children's Health Research Alliance Board. He was previously Non-Executive Director of Research Australia (2005 ­-2012) and the Gold Coast Hospital and Health Services Board (2011-­ 2017).